Sort
130,381 grants matching “hiv”
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
$882,250Steven M Wolinsky · Northwestern University At Chicago · R01 · FY2014 · DA
Project 1
$882,196John D Gross · University Of California, San Francisco · U54 · FY2022 · AI
IMPROVING COMBINED BUPRENORPHINE-BEHAVIORAL TREATMENT
$882,167University Of Vermont &St Agric College · R01 · FY2002 · DA
Clonal Analysis of the Human B Cell Response to HIV
$882,141James E Crowe · Vanderbilt University · U01 · FY2009 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$882,067Michael R. Farzan · Scripps Florida · R37 · FY2020 · AI
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$882,023Shane P Crotty · La Jolla Institute For Immunology · R37 · FY2024 · AI
Structural characterization of MPER-TM immunogens
$881,996Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2025 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$881,965Joseph E Robertson · Oregon Health & Science University · P51 · FY2009 · RR
Orbitrap Exploris 480 Mass Spectrometer for Biomedical Research
$881,950Susan T Weintraub · University Of Texas Hlth Science Center · S10 · FY2022 · OD
Role of p38 MAPK activation in AIDS pathogenesis
$881,950Anna Aldovini · Boston Children'S Hospital · R01 · FY2014 · AI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
$881,947Amelia Escolano · Wistar Institute · R01 · FY2025 · AI
Cell-Surface Interactions in Pathogenesis
$881,922Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence
$881,878Jia Zhu · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
HIV Disease, Drug Abuse, &Nutrient Therapy in Botswana
$881,866Florida International University · R01 · FY2005 · DA
A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting
$881,830Michael Scott Gordon · Friends Research Institute, Inc. · R01 · FY2023 · DA
Central memory CD4 T cell infection: key role in ART response and HIV persistence
$881,672Mirko Paiardini · Emory University · R01 · FY2015 · AI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution
$881,590Raiees Ahmad Andrabi · Scripps Research Institute, The · R01 · FY2022 · AI
CombinADO: a combination intervention strategy to improve health outcomes for adolescents living with HIV
$881,536Elaine Janine Abrams · Columbia University Health Sciences · UH3 · FY2022 · HD
Einstein-Mount Sinai Diabetes Research Center
$881,475Jeffrey E Pessin · Albert Einstein College Of Medicine · P30 · FY2015 · DK
CLINICAL IMPACT ON HCV &ALCOHOL IN HIV INFECTED PERSONS
$881,468Boston Medical Center · R01 · FY2003 · AA
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population
$881,450Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R24 · FY2024 · OD
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$881,449Leonidas A Stamatatos · Seattle Biomedical Research Institute · U19 · FY2014 · AI
Evolution and Latency of T-Tropic and M-Tropic HIV in People Infected with Subtype C
$881,439Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · R01 · FY2025 · MH
Optimizing AAV delivery of bNAbs for HIV prevention
$881,378Matthew Ryan Gardner · Emory University · R01 · FY2025 · AI
Closing the Gaps on Buruli Ulcer Diagnosis, Treatment, and Prevention
$881,258Eric L Nuermberger · Johns Hopkins University · R01 · FY2018 · AI